Literature DB >> 27021276

Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse.

Stephen T Ferris1, Javier A Carrero1, Emil R Unanue2.   

Abstract

This is a brief summary of our studies of NOD autoimmune diabetes examining the events during the initial stage of the process. Our focus has been on antigen presentation events and the antigen presenting cells (APC) inside islets. Islets of non-diabetic mice contain resident macrophages that are developmentally distinct from those in the inter-acinar stroma. The autoimmune process starts with the entrance of CD4+ T cells together with a burst of a subset of dendritic cells (DC) bearing CD103. The CD103+ DC develop under the influence of the Batf3 transcription factor. Batf3 deficient mice do not develop diabetes and their islets are uninfiltrated throughout life. Thus, the CD103+ DC are necessary for the progression of autoimmune diabetes. The major CD4+ T cell response in NOD are the T cells directed to insulin. In particular, the non-conventional 12-20 segment of the insulin B chain is presented by the class II MHC molecule I-A(g7) and elicits pathogenic CD4+ T cells. We discuss that the diabetic process requires the CD103+ DC, the CD4+ T cells to insulin peptides, and NOD specific I-Ag(7) MHC-II allele. Finally, our initial studies indicate that beta cells transfer insulin containing vesicles to the local APC in a contact-dependent reaction. Live images of beta cells interactions with the APC and electron micrographs of islet APCs also show the transfer of granules.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen presenting cells; Antigen processing; Autoimmune diabetes; Non-obese diabetic; T cells

Mesh:

Substances:

Year:  2016        PMID: 27021276      PMCID: PMC4903912          DOI: 10.1016/j.jaut.2016.03.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

1.  Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells.

Authors:  Anthony N Vomund; Bernd H Zinselmeyer; Jing Hughes; Boris Calderon; Carolina Valderrama; Stephen T Ferris; Xiaoxiao Wan; Kohsuke Kanekura; Javier A Carrero; Fumihiko Urano; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

2.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

3.  Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.

Authors:  Boris Calderon; Javier A Carrero; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes.

Authors:  Matteo G Levisetti; Anish Suri; Katherine Frederick; Emil R Unanue
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

5.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

Review 6.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

7.  Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes.

Authors:  James F Mohan; Matteo G Levisetti; Boris Calderon; Jeremy W Herzog; Shirley J Petzold; Emil R Unanue
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

8.  Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse.

Authors:  Javier A Carrero; Boris Calderon; Fadi Towfic; Maxim N Artyomov; Emil R Unanue
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Insulin, not C-peptide (proinsulin), is present in crinophagic bodies of the pancreatic B-cell.

Authors:  L Orci; M Ravazzola; M Amherdt; C Yanaihara; N Yanaihara; P Halban; A E Renold; A Perrelet
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

10.  The pancreas anatomy conditions the origin and properties of resident macrophages.

Authors:  Boris Calderon; Javier A Carrero; Stephen T Ferris; Dorothy K Sojka; Lindsay Moore; Slava Epelman; Kenneth M Murphy; Wayne M Yokoyama; Gwendalyn J Randolph; Emil R Unanue
Journal:  J Exp Med       Date:  2015-09-07       Impact factor: 14.307

View more
  9 in total

Review 1.  miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.

Authors:  Ying Zheng; Zhen Wang; Zhiguang Zhou
Journal:  Cell Mol Immunol       Date:  2017-03-20       Impact factor: 11.530

Review 2.  Beyond Genetics: What Causes Type 1 Diabetes.

Authors:  Zhen Wang; Zhiguo Xie; Qianjin Lu; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

3.  Regulatory B Cells in Type 1 Diabetes.

Authors:  Joanne Boldison; Larissa Camargo Da Rosa; F Susan Wong
Journal:  Methods Mol Biol       Date:  2021

4.  HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression.

Authors:  Jennifer Schloss; Riyasat Ali; Jeremy J Racine; Harold D Chapman; David V Serreze; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2018-04-09       Impact factor: 5.422

Review 5.  Autoreactive T cells in type 1 diabetes.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2017-08-01       Impact factor: 14.808

6.  Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation.

Authors:  Ashley E Ciecko; Bardees Foda; Jennifer Y Barr; Sheela Ramanathan; Mark A Atkinson; David V Serreze; Aron M Geurts; Scott M Lieberman; Yi-Guang Chen
Journal:  Cell Rep       Date:  2019-12-03       Impact factor: 9.423

Review 7.  Evolving Antibody Therapies for the Treatment of Type 1 Diabetes.

Authors:  Qi Ke; Charles J Kroger; Matthew Clark; Roland M Tisch
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 8.  Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis.

Authors:  Yang Li; Fei Sun; Tian-Tian Yue; Fa-Xi Wang; Chun-Liang Yang; Jia-Hui Luo; Shan-Jie Rong; Fei Xiong; Shu Zhang; Cong-Yi Wang
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

Review 9.  Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes.

Authors:  Qing-Rong Liu; Kanikkai Raja Aseer; Qin Yao; Xiaoming Zhong; Paritosh Ghosh; Jennifer F O'Connell; Josephine M Egan
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.